Sample series to differentiate target nucleic acids from contaminant nucleic acids

US11674167B2 · kind B2 · utility

Assignee

• KARIUS, INC. · US

Inventors

• Timothy A. Blauwkamp · Palo Alto, US
• Liza Huijse · Redwood City, US
• Michael Rosen · Palo Alto, US
• Igor D. Vilfan · East Palo Alto, US

Key dates

• Filing date: May 27, 2020
• Grant date: Jun 13, 2023
• Expiry date: Dec 1, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2565/102
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

This disclosure provides methods, compositions and kits for determining if nucleic acids detected in a sample such as a clinical sample are derived from contaminant pathogens or clinically-relevant pathogens.